← Back to Search

Vit.D3 5000 IU, Immune Active for Immune Response (LIFEHOUSE Trial)

N/A

Waitlist Available

Led By Josesph J Lamb, MD

Research Sponsored by Metagenics, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks (phase 1) or up to 6 months (phase 2)

Awards & highlights

LIFEHOUSE Trial Summary

This trial will offer employees complimentary supplementation with commercially available nutritional supplements to help improve their immune health. The results will be measured by blood parameters and questionnaire responses.

LIFEHOUSE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks (phase 1) or up to 6 months (phase 2)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks (phase 1) or up to 6 months (phase 2)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks (phase 1) or up to 6 months (phase 2) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The benefit of nutritional supplements (Vit.D3 5000, Immune Active) on the improvement of health.

Secondary outcome measures

The benefit of nutritional supplements (Vit.D3 5000, Immune Active) on the improvement of quality of life.

The benefit of nutritional supplements (Vit.D3 5000, Immune Active) on the improvement of the absence of infections.

The benefit of nutritional supplements (Vit.D3 5000, Immune Active) on the improvement of weight and body composition.

LIFEHOUSE Trial Design

1Treatment groups

Experimental Treatment

Group I: Immune responseExperimental Treatment1 Intervention

This is a single-arm study. All subjects will be treated equally and will receive the same type and amount of nutritional supplements.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Vit.D3 5000 IU, Immune Active

2021

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Metagenics, Inc.Lead Sponsor

14 Previous Clinical Trials

1,409 Total Patients Enrolled

MetaProteomics LLCIndustry Sponsor

6 Previous Clinical Trials

1,044 Total Patients Enrolled

Josesph J Lamb, MDPrincipal InvestigatorMedical Director

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to volunteer for this clinical trial?

"For this study, seven candidates with immune responses between 18 and 69 are being recruited. To meet the criteria they must be male or female; employees at one of Metagenics' four locations in Gig Harbor, VA, Lenexa KS and Santa Fe Springs CA; possess a state of general good health; as well as provide written consent for their involvement in the trial."

Answered by AI

Is there a call for new participants in this experiment?

"Clinicaltrials.gov has reported that this trial is no longer searching for participants after its posting in January 2021 and the latest update from April 2022. Nonetheless, there are 7 other trials currently enrolling patients."

Answered by AI